Fragmented QRS reflects disturbances in the myocardium predisposing the heart to ventricular tachyarrhythmias. Recent studies suggest that fragmented QRS (fQRS) is associated with worse major arrhythmic events in hypertrophic cardiomyopathy (HCM). However, a systematic review and meta-analysis of the literature has not been done. We assessed the association between fQRS and major arrhythmic events in hypertrophic cardiomyopathy by a systematic review of the literature and a meta-analysis.
| INTRODUCTION
Hypertrophic cardiomyopathy (HCM) is a common inherited disease of the heart muscle. The prevalence of the disease in the general population is approximately 1 in 500 (Maron et al., 2014) . Some patients may remain asymptomatic throughout life but others may experience heart failure symptoms or sudden cardiac arrest. Symptomatic HCM is a now much more manageable condition with improved options for SCA prevention (e.g., subcutaneous implantable defibrillator) and invasive treatments of outflow tract obstruction (Maron et al., 2014) . Nonetheless, identification of patients at high risk of SCA or sudden cardiac death remains challenging.
The twelve-lead ECG is one of the most common, useful and costeffective investigations performed in clinical settings. Fragmented QRS (fQRS) is a marker of myocardial scar and identifies high-risk patients in various cardiac conditions, including acute coronary syndrome, cardiac sarcoidosis, Brugada syndrome, acquired long QT syndrome, or idiopathic dilated cardiomyopathy (Das, Khan, Jacob, Kumar, & Mahenthiran, 2006; Sha et al., 2011; Take & Morita, 2012) . Recent studies suggest that fQRS is associated with increased major arrhythmic events in patients with HCM (Debonnaire et al., 2015; Femenia et al., 2013; Kang et al., 2014; Nomura et al., 2015; Ozyilmaz et al., 2017) . However, no systematic review or meta-analysis of literature has been done to address the association in this group of patients.
Therefore, we performed a systematicmeta-analysis to establish the association between fQRS and major arrhythmic events in HCM.
| METHOD

| Search strategy
Two investigators (CK and PC) independently searched for published studies indexed in MEDLINE and EMBASE databases from inception to January 2017 using a search strategy that included the terms "fragmented QRS", "QRS fragmentation" and "hypertrophic cardiomyopathy" (described in Data S1). Only English language publications were included. A manual search for additional pertinent studies and review articles using references from retrieved articles was also completed.
| Inclusion criteria
The eligibility criteria included the following:
1. Cohort studies (prospective or retrospective) reporting incidence of major arrhythmic events (MAE) including sustained ventricular tachycardia, sudden cardiac arrest, or sudden cardiac death) in HCM patients with and without fQRS.
2.
Relative risk, hazard ratio, odds ratio, incidence ratio, or standardized incidence ratio with 95% confidence intervals or sufficient raw data for these calculations had to be provided.
3. HCM participants without fQRS were used as controls.
Study eligibility was independently determined by two investigators (TR and NK) and differences were resolved by mutual consensus.
Newcastle-Ottawa quality assessment scale was used to evaluate each study in three domains: recruitment and selection of the participants, similarity and comparability between the groups, and ascertainment of the outcome of interest among cohort studies (Stang, 2010) .
| Data extraction
A standardized data collection form was used to obtain the following information from each study: title of study, name of first author, year of study, year of publication, country of origin, number of participants, demographic data of participants, method used to identify cases and controls, method used to diagnose the outcomes of interest (fQRS and major arrhythmic events), and average duration of follow-up.
Confounders were also assessed and adjusted effect estimates with 95% confidence interval 95% confidence intervals and covariates were included in the multivariable analysis.
To ensure accuracy, all investigators independently performed this data extraction process. Any data discrepancy was resolved by referring back to the original articles.
| Statistical analysis
We performed a meta-analysis of the included cohort studies using a random-effects model. The extracted studies were excluded from the analysis if they did not present an outcome in each intervention group or did not have enough information required for continuous data comparison. We pooled the point estimates from each study using the generic inverse-variance method of DerSimonian and Laird (1986) . The heterogeneity of effect size estimates across these studies was quantified using the I 2 statistic and Q statistic. For the Q statistic, substantial heterogeneity was defined as p < .10. The I 2 statistic ranges in value from 0% to 100% (I 2 < 25%, low heterogeneity; I 2 = 25%-50%, moderate heterogeneity; and I 2 > 50%, substantial heterogeneity; Higgins, Thompson, Deeks, & Altman, 2003) . A sensitivity analysis was performed to assess the influence of the individual studies on the overall results by omitting one study at a time.
Publication bias was assessed using funnel plot and Egger's regression test (Sterne & Egger, 2001 ; p < .05 was considered significant). All data analyses were performed using the Stata SE 14.1 software from StataCorp LP.
| RESULT
| Description of included studies
Our search strategy yielded 15 potentially relevant articles (eight articles from EMBASE and seven articles from MEDLINE). After exclusion of three duplicate articles, 12 articles underwent title and abstract review. One article was excluded because it was an abstract presentation. Six articles were excluded at this stage since they were not cohort studies, did not report the outcome of interest (MAE) or
were not conducted in patients with HCM, leaving five articles for fulllength article review. Therefore, three retrospective and two prospective cohort studies of HCM patients (205 fQRS and 468 non-fQRS controls) were included in this meta-analysis. Figure 1 outlines the search and literature review process. The clinical characteristics and summary of included studies are described in Table 1 .
| Quality assessment of included studies
Newcastle-Ottawa scales of the included studies are described in the Table S1 . The Newcastle-Ottawa scale uses a star system (0-9)
to evaluate included studies on three domains: selection, comparability, and outcomes. Higher scores represent higher study quality.
Intra-study risks of bias of included studies are also described in Table S2 .
| Meta-analysis results
Five studies from January 2013 to May 2017 were included in this meta-analysis. All of five studies did reveal an increased MAE among HCM patients with fQRS with four of the five studies achieving statistical significance. The pooled analysis demonstrated a statistically significant increased risk of MAE in HCM patients with fQRS compared to non-fQRS HCM patients with the pooled risk ratio of 7.29 (95% confidence interval: 4.00-13.29, p < .001, I 2 = 0%). There was no statistical heterogeneity observed. Forest plot of our meta-analysis is shown in Figure 2 .
| Sensitivity analysis
To assess the stability of the results of the meta-analysis, we conducted a sensitivity analysis by excluding one study at a time. The results were not significantly altered indicating that our findings were robust.
| Publication bias
To investigate potential publication bias, we examined the contourenhanced funnel plot of the included studies in assessing change in log OR of death or composite outcome (Figure 3 ). The vertical axis represents study size (standard error) while the horizontal axis represents effect size (log odds ratio). From this plot, distribution of studies on both sides of the mean was symmetrical. The Egger's test was significant (p = .568) and confirmed no small study bias.
F I G U R E 1 Search methodology and selection process
Potentially relevant articles identified from search of MEDLINE (n = 7) and EMBASE database (n = 8) and screened for retrieval 
| DISCUSSION
Hypertrophic cardiomyopathy is a complex inherited heart disease and one of the most common causes of sudden cardiac death (SCD) in young adults. Multiple approaches to management of the patient should be taken into consideration. Prevention of SCD is a critical part of caring for the HCM patient. The overall risk of SCD in HCM patients is about 1% per year (Gersh et al., 2011) . Recommended prevention strategies include exercise restriction, anti-arrhythmic drugs, and ICD.
Identifying those who would benefit from an ICD is challenging but T A B L E 1 (Continued) an essential part of clinical decision-making. Recommendations are based on cohort studies that identify relationships between clinical characteristics and prognostic outcomes.
Our meta-analysis summarized all available evidence of MAE in HCM from five studies, a total of 779 patients. Fragmented QRS was present in 46% of the studied population. Our study revealed that HCM patients with fQRS have a statistically significant increased risk of MAE compared to those without fQRS (pooled risk ratio of 7.29, 95% CI 4.00-13.29, p < .001, I 2 = 0%). This result stresses the importance of integrating fQRS into risk stratification of HCM for SCD in clinical practice.
The importance of fQRS, which is suggestive of myocardial scarring and fibrosis, has been increasingly supported by recent studies of MAE in various cardiac diseases (Das et al., 2006; Konno et al., 2015; Lu et al., 2017; Sha et al., 2011; Take & Morita, 2012) , including HCM (Debonnaire et al., 2015; Konno et al., 2015; Lu et al., 2017) . Fibrosis or tissue heterogeneity increases susceptibility to reentry and arrhythmias. The presence of fQRS is more common in patients with high-risk characteristics, such as family history of SCD, history of syncope, and HCM patients with a calculated HCM Risk-SCD score >6% (Ozyilmaz et al., 2017) . The strength of the association of fQRS with MAE may depend on observed territory of distribution (Femenia et al., 2013; Kang et al., 2014) . A previous study of HCM patients found that the presence of fQRS in more than two territories has a positive predictive value of 33% and negative predictive value of 88% of MAE or sudden cardiac death (Debonnaire et al., 2015) . has been shown to increase the positive predictive value from 8% to 20% and specificity from 72% to 92% in patients with one risk factor (NEED REF). Specificity was increased from 88% to 94% in patients with at least two risk factors (Kang et al., 2014) . Addition of fQRS to traditional markers significantly improved the specificity and positive predictive value of future MAEs in "low risk" patients as well (Kang et al., 2014) .
| Limitation
In our meta-analysis, there were some limitations that could limit its generalizability. First, all of the studies included were cohorts which are observational in nature. Three out of five studies were retrospective. Secondly, our meta-analysis was only focused on MAE. Given the published outcomes available for study, we did not take overall mortality or total cardiovascular mortality into account. However, the recent study from Lu et al. (2017) shows that fQRS is associated with increased all-cause mortality, cardiovascular disease mortality, and heart failure related death. In addition, our data is not sufficient to determine the relationship between fQRS and other ECG parameters such as prolonged QTc F I G U R E 2 Forest plot of the included studies assessing the association between fragmented QRS and major arrhythmic events Favors non-fragmented QRS Favors fragmented QRS logrr or territory of fQRS to the outcome of interest. According to Debonnaire et al. (2015) , prolonged QTc is an independent predictor of ventricular arrhythmias and sudden cardiac death. Finally, there was some heterogeneity amongst the studies. However, we used sensitivity analysis methods in the random-effects model and found no difference between the imputed risk ratio and its 95% confidence interval.
| CONCLUSION
In conclusion, we found that baseline fQRS significantly increased the risk of MAE in HCM patients. fQRS should be considered as an important factor when considering primary prevention ICD implantation in HCM patients. Further study is needed to establish the role of fQRS in risk stratification for SCD in patients with HCM.
